Stockholders approve extension of Bellevue Life Sciences SPAC deadline to Feb 2025; 44% of shares redeemed

OSR Holdings, Inc.

Charter amended to extend business combination deadline from Nov 14, 2024 to Feb 14, 2025.
Charter amended to remove net tangible asset requirement to avoid penny stock rules.
1,766,469 shares (approx. 44% of outstanding) tendered for redemption.
Five existing directors re-elected at annual meeting.
Quorum was 71.24% of outstanding shares; proposals approved overwhelmingly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.